20, 1; 91, 1) effektivitet mod alvorlig rotavirus gastro- enteritis (Vesikari- score > 11) forårsaget af rotavirus type G2P[ 4] i løbet af det første leveår. * I disse undersøgelser var punktestimater og konfidensintervaller henholdsvis:
A pooled analysis of five efficacy studies*, showed a 71.4% (95% CI:20.1;91.1) efficacy against severe rotavirus gastro-enteritis (Vesikari score ≥11) caused by rotavirus G2P[4] type during the first year of life. * In these studies, the point estimates and confidence intervals were respectively: